First Allied Advisory Services’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $732K | Sell |
6,400
-1,711
| -21% | -$196K | 0.02% | 577 |
|
|
2020
Q2 | $910K | Sell |
8,111
-4,856
| -37% | -$545K | 0.03% | 465 |
|
|
2020
Q1 | $1.16M | Buy |
12,967
+5,160
| +66% | +$463K | 0.05% | 361 |
|
|
2019
Q4 | $845K | Buy |
7,807
+4,812
| +161% | +$521K | 0.03% | 535 |
|
|
2019
Q3 | $295K | Buy |
+2,995
| New | +$295K | 0.01% | 904 |
|
|
2016
Q1 | – | Sell |
-1,083
| Closed | -$205K | – | 1140 |
|
|
2015
Q4 | $205K | Buy |
+1,083
| New | +$205K | 0.01% | 961 |
|